These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1298 related items for PubMed ID: 16555292

  • 1. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B, Takahashi M, Endo K, Buyankhuu O, Baatarkhuu O, Nishizawa T, Okamoto H.
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [Abstract] [Full Text] [Related]

  • 2. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B, Takahashi M, Endo K, Agiimaa D, Buyankhuu O, Ninomiya M, Lorenzo FR, Okamoto H.
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H.
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [Abstract] [Full Text] [Related]

  • 6. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC.
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [Abstract] [Full Text] [Related]

  • 7. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
    Abe K, Hayakawa E, Sminov AV, Rossina AL, Ding X, Huy TT, Sata T, Uchaikin VF.
    J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.
    Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H.
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):392-8. PubMed ID: 15013993
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [Abstract] [Full Text] [Related]

  • 10. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S, Mahmoodi MF, Andalibi S, Solati AA.
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [Abstract] [Full Text] [Related]

  • 11. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J.
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [Abstract] [Full Text] [Related]

  • 12. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients.
    Bozdayi AM, Aslan N, Bozdayi G, Türkyilmaz AR, Sengezer T, Wend U, Erkan O, Aydemir F, Zakirhodjaev S, Orucov S, Bozkaya H, Gerlich W, Karayalçin S, Yurdaydin C, Uzunalimoğlu O.
    Arch Virol; 2004 Nov; 149(11):2115-29. PubMed ID: 15503201
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Virological and clinical characteristics of delta hepatitis in Central Europe.
    Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H.
    J Viral Hepat; 2009 Dec; 16(12):883-94. PubMed ID: 19566789
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM.
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [Abstract] [Full Text] [Related]

  • 18. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
    Ozyilkan E, Tatar G, Köseoğlu T, Ozkuyumcu C, Kayhan B, Telatar H.
    Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
    [Abstract] [Full Text] [Related]

  • 19. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    Hepatology; 2001 Oct; 34(4 Pt 1):817-23. PubMed ID: 11584381
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, Lascoux-Combe C, Serfaty L, Gault E, Desvarieux M, Girard PM.
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.